Eur Rev Med Pharmacol Sci 2022; 26 (10): 3642-3647
DOI: 10.26355/eurrev_202205_28859

Clinical effect of unilateral balloon infusion of low dose bone cement in PKP for osteoporotic thoracolumbar compression fractures in the elderly

L.-M. Lu, X.-H. Ni, J.-P. Ni, W. Tan, X.-Y. Zhu, S. Yin, J.-S. Wu, F.-C. Xu, Q.-M. Zhao

Department of Orthopedics, Suzhou Kowloon Hospital, Shanghai Jiaotong University, School of Medicine, Suzhou, Jiangsu, China. doctoryy6688@163.com


OBJECTIVE: The study was undertaken to determine the clinical effectiveness of percutaneous kyphoplasty (PKP) with unilateral balloon infusion of low dose of bone cement for treatment of osteoporotic vertebral compression fractures (OVCFs) in the elderly.

PATIENTS AND METHODS: A retrospective study was carried out. A total of 36 patients with OVCFs treated by PKP from August 2019 and August 2020 were included. Patients were divided into two groups according to the amount of bone cement infused into the vertebral body. The amount of cement in conventional-dose group was 3.5-6.0 mL and the amount of cement in small-dose group was 1.8-3.0 mL. Pain relief before and after the operation were evaluated, and the leakage of bone cement in the two groups was also observed.

RESULTS: Two groups of patients have obtained a good clinical efficacy. Pain has significant differences before and after the operation (p < 0.05). More importantly, compared with conventional-dose group, small-dose group has lower bone cement leakage rate (p < 0.05).

CONCLUSIONS: PKP with small-dose bone cement infusion can obtain the same clinical effects of conventional-dose, but the incidence of bone cement leakage is lower and safe.

Free PDF Download

To cite this article

L.-M. Lu, X.-H. Ni, J.-P. Ni, W. Tan, X.-Y. Zhu, S. Yin, J.-S. Wu, F.-C. Xu, Q.-M. Zhao
Clinical effect of unilateral balloon infusion of low dose bone cement in PKP for osteoporotic thoracolumbar compression fractures in the elderly

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 10
Pages: 3642-3647
DOI: 10.26355/eurrev_202205_28859